EUVIMEDEUVIMED entdecken
Open Access

Intraosseous vs Intravenous Access for Epinephrine in Pediatric Out-of-Hospital Cardiac Arrest

Masashi Okubo, Sho Komukai, Junichi Izawa, SunHee Chung, Cameron Dezfulian, Francis X Guyette, Joshua R Lupton, Christian Martin-Gill, Sylvia Owusu-Ansah, Sriram Ramgopal, Clifton W Callaway

JAMA Network Open · 2025

DOI: 10.1001/jamanetworkopen.2025.17291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2025. Verfasst von Masashi Okubo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Epinephrine, Out-of-Hospital Cardiac Arrest, Infusions, Intraosseous, Vasoconstrictor Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIMHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance While epinephrine is commonly administered in children with out-of-hospital cardiac arrest (OHCA) via an intraosseous (IO) or intravenous (IV) route, the optimal route of epinephrine delivery is unclear.

Objective

To evaluate the association between the route of epinephrine administration (IO or IV) and patient outcomes after pediatric OHCA. Design, Setting, and Participants Retrospective cohort study of pediatric patients (aged <18 years) with nontraumatic OHCA treated by emergency medical services who received prehospital epinephrine either via an IO or IV route. Patients were included in the Resuscitation Outcomes Consortium Epidemiologic Registry, a prospective OHCA registry at 10 sites in the US and Canada from April 2011 to June 2015. Data analysis was performed from May 2024 to April 2025. Exposure Epinephrine administration route: IO or IV route. Main Outcomes and Measures The primary outcome was survival to hospital discharge. The secondary outcome was return of spontaneous circulation (ROSC) before hospital arrival. Propensity scores were calculated and inverse probability of treatment weighting (IPTW) was performed with stabilized weights to control imbalances in measured patient demographics, cardiac arrest characteristics, and bystander and prehospital interventions.

Results

Of 739 eligible patients (median [IQR] age, 1 [0-11] years), 449 (60.8%) were male. Epinephrine was administered via an IO route for 535 (72.4%) and via an IV route for 204 (27.6%) patients. In the IPTW pseudopopulation (740 weighted cases), there was no significant difference in survival to hospital discharge (IO epinephrine: 28 of 528 patients [5.3%] vs IV epinephrine: 12 of 212 patients [5.7%]; risk ratio [RR], 0.92; 95% CI, 0.41-2.07) or prehospital ROSC (IO epinephrine: 76 of 528 patients [14.4%] vs IV epinephrine: 46 of 212 patients [21.7%]; RR, 0.66; 95% CI, 0.42-1.03) between the IO and IV epinephrine groups. Conclusions and Relevance In this retrospective cohort study of pediatric patients with OHCA in the US and Canada, the route of epinephrine administration was not associated with survival to hospital discharge or prehospital ROSC. This may support the practice of administering epinephrine via IO or IV route.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpinephrineOut-of-Hospital Cardiac ArrestInfusions, IntraosseousVasoconstrictor AgentsHumansMaleFemaleChildRetrospective StudiesChild, PreschoolInfantCanadaEmergency Medical ServicesAdministration, IntravenousAdolescentRegistriesUnited StatesCardiopulmonary Resuscitation

Substanzen

EpinephrineVasoconstrictor Agents

Autor:innen und Institutionen

  • Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Division of Biomedical Statistics, Department of Integrated Medicine, Osaka University, Graduate School of Medicine, Osaka, Japan.
  • Division of Intensive Care Medicine, Okinawa Prefectural Chubu Hospital, Okinawa, Japan.
  • Department of Preventive Services, Kyoto University Graduate School of Public Health, Kyoto, Japan.
  • Department of Emergency Medicine, Oregon Health and Science University, Portland.
  • Division of Pediatric Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston.

Förderung

  • NHLBI NIH HHS
  • NIMHD NIH HHS

Zitieren

APA

Okubo, M., Komukai, S., Izawa, J., Chung, S., Dezfulian, C., Guyette, F. X., Lupton, J. R., Martin-Gill, C., Owusu-Ansah, S., Ramgopal, S., & Callaway, C. W. (2025). Intraosseous vs Intravenous Access for Epinephrine in Pediatric Out-of-Hospital Cardiac Arrest. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.17291

Vancouver

Okubo M, Komukai S, Izawa J, Chung S, Dezfulian C, Guyette FX, et al. Intraosseous vs Intravenous Access for Epinephrine in Pediatric Out-of-Hospital Cardiac Arrest. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.17291

BibTeX
@article{Okubo2025,
  author = {Okubo, Masashi and Komukai, Sho and Izawa, Junichi and Chung, SunHee and Dezfulian, Cameron and Guyette, Francis X and Lupton, Joshua R and Martin-Gill, Christian and Owusu-Ansah, Sylvia and Ramgopal, Sriram and Callaway, Clifton W},
  title = {Intraosseous vs Intravenous Access for Epinephrine in Pediatric Out-of-Hospital Cardiac Arrest},
  journal = {JAMA Network Open},
  year = {2025},
  doi = {10.1001/jamanetworkopen.2025.17291}
}
Kostenlos starten →